RT Journal Article
SR Electronic
T1 650 Neoadjuvant ezabenlimab or pembrolizumab in combination with an anti-SIRPα antibody in resectable colorectal cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A741
OP A741
DO 10.1136/jitc-2023-SITC2023.0650
VO 11
IS Suppl 1
A1 Lucas, Natalie
A1 Venturini, Nicholas
A1 Hegde, Samarth
A1 Mattiuz, Raphaël
A1 Hennequin, Clotilde
A1 Berichel, Jessica Le
A1 Chin, Theodore
A1 Reid, Amanda
A1 Troncoso, Leanna
A1 Greenwald, David
A1 Grinspan, Ari
A1 Itzkowitz, Steve
A1 Lucas, Aimee L
A1 Zalkin, Dana
A1 Ang, Celina
A1 Acuna-Villaorduna, Ana
A1 Kozuch, Peter
A1 Khaitov, Sergey
A1 Ky-Miyasaka, Alex
A1 Sarpel, Umut
A1 Steinhagen, Randolph
A1 Sylla, Patricia
A1 Kretschmar, Gunther
A1 Zhu, Zheng
A1 Harpaz, Noam
A1 Liu, Qingqing
A1 Paulsen, John
A1 Wang, Xintong
A1 Ward, Stephen
A1 Doroshow, Deborah
A1 Polydorides, Alexandros D
A1 Cohen, Deirdre
A1 Merad, Miriam
A1 Wu, Kathy
A1 Fazilov, Gabriela
A1 Shelton, Gary
A1 Marron, Thomas
A1 Cameron, Amber
A1 Yuan, Megan
A1 Fitzgerald, Lisa
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A741.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.